Tweet Archive for November 2014 « page 10

Assessment of a new combination of retinoids and depigmenting agents for melasma onlinelibrary.wiley.com/doi/10.1111/jo… #dermatology

11:57am Nov 18 2014 —

Botulinum toxin type A and resistance – rare but need to be monitored & studies needed ncbi.nlm.nih.gov/pubmed/2539962… #Xeomin #Botox and #Dysport

11:52am Nov 18 2014 —

Clinical resistance to 3 types of botulinum toxin typeA in aesthetic medicine. ncbi.nlm.nih.gov/pubmed/2539962… @Allergan @Galderma Ipsen Pharma Merz

11:43am Nov 18 2014 —

Aesthetic dermatology and emotional well-being questionnaire. ncbi.nlm.nih.gov/pubmed/2539962… #cosmeticdermatology

11:37am Nov 18 2014 —

RT @ibtimesindia1: #Allergan and #Actavis Agree to $66 Billion Acquisition Deal;
#Valeant Loses Hostile Bid
bit.ly/1yOxvF6

4:32am Nov 18 2014 —

RT @DermatologyPC: Check out these interesting skin facts! #Dermatology #Foxboro #Franklin #Norwood pic.twitter.com/5ma69NPcIZ #skincancer

in reply to DermatologyPC — 4:25am Nov 18 2014 —

RT @beapen: Topical oxidized #glutathione and skin whitening gulfdoctor.net/s/dd #dermatology”

in reply to beapen — 4:23am Nov 18 2014 —

ATX-101 for the Reduction of Submental Fat; Pooled Analysis of Safetyc& Efficacy Results of 2 pivotal RCT @prsjournal ncbi.nlm.nih.gov/pubmed/25254847

2:26am Nov 18 2014 —

What Is Sensitive Skin? A Systematic Literature Review of Objective Measurements ncbi.nlm.nih.gov/pubmed/25322670 #sensitiveskin

2:15am Nov 18 2014 —

Pachydermoperiostosis: aesthetic treatment of prematurely aging face with facelift and botulinum toxin a ncbi.nlm.nih.gov/pubmed/25377981

2:11am Nov 18 2014 —